Bryos Pharmaceutical Private Limited
About Bryos Pharmaceutical Private Limited
Data last updated:
Bryos Pharmaceutical Private Limited is a private limited company based in Dhaniv, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2019PTC331568. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajendra Shivmurti Yadav and Sanju Rajendra Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S. No. 119 Room No. 04 Satnam Saheb Chawl Opp. Mahatma Phule School, Dhaniv, Maharashtra, India – 401208.
As per the financials filed for FY 2024, the company reported a revenue of ₹40 Lakh, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹78,417 (net margin 2%) and EBITDA of ₹86,308 (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressS. No. 119 Room No. 04 Satnam Saheb Chawl Opp. Mahatma Phule School, Dhaniv, Maharashtra, India – 401208
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bryos Pharmaceutical Private Limited
The main business activity of Bryos Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bryos Pharmaceutical Private Limited FY 2025 filings available
Bryos Pharmaceutical Private Limited reported revenue of ₹40 Lakh (up 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Bryos Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 39% over three years, including 12% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bryos Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹86,308 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹78,417 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bryos Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bryos Pharmaceutical are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bryos Pharmaceutical Private Limited
Bryos Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| LN Life Sciences Private Limited | ₹41.18 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Vaamveda Healthcare Private Limited | ₹40.96 Lakh (FY 2025) | •••• | •••• | 87.0% | •••• | Bishrakh, Uttar Pradesh, India |
| Concept Laboratories Pvt Ltd | ₹40.42 Lakh (FY 2024) | •••• | •••• | 170.0% | •••• | Mumbai, Maharashtra, India |
| Damao Pharmaceutical Private Limited | ₹40.14 Lakh (FY 2025) | •••• | •••• | -77.0% | •••• | Nani Daman, Daman and Diu, India |
| Blazed Pharmaceuticals Private Limited | ₹40.08 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Bryos Pharmaceutical Private Limited this company | ₹40 Lakh (FY 2024) | •••• | •••• | 12.0% | •••• | Dhaniv, Maharashtra, India |
| Medowin India Private Limited | ₹39.69 Lakh (FY 2024) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Astra Unique Prohealth Private Limited | ₹39.31 Lakh (FY 2025) | •••• | •••• | -21.0% | •••• | Delhi, India |
| Sachkar Pharmaceuticals Private Limited | ₹38.98 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Bangalore, Karnataka, India |
| Skingineers Private Limited | ₹38.94 Lakh (FY 2025) | •••• | •••• | 33.0% | •••• | Mumbai, Maharashtra, India |
| Innomedix Pharma Private Limited | ₹38.91 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Bryos Pharmaceutical by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Bryos Pharmaceutical Private Limited
Bryos Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Shivmurti Yadav | Director | 11 Oct 2019 | 6 Years 11 Months | Current |
| Sanju Rajendra Yadav | Director | 11 Oct 2019 | 6 Years 11 Months | Current |
Ownership and Shareholding of Bryos Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bryos Pharmaceutical Private Limited
Bryos Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bryos Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Bryos Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bryos Pharmaceutical Private Limited
Bryos Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Rajendra Shivmurti Yadav was appointed as Director on 11 Oct 2019.
Credit Ratings, Litigation & Regulatory Alerts for Bryos Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bryos Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bryos Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bryos Pharmaceutical Private Limited
Bryos Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bryos Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bryos Pharmaceutical Private Limited
Bryos Pharmaceutical is an active private limited company based in Dhaniv, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 October 2019 (7+ years old) and is registered under CIN U24239MH2019PTC331568.
Bryos Pharmaceutical reported revenue of ₹40 Lakh for FY 2024 (up 12% YoY).
Bryos Pharmaceutical has 2 current directors:
- Rajendra Shivmurti Yadav - Director
- Sanju Rajendra Yadav - Director
Bryos Pharmaceutical reported a net profit of ₹78,417 (net margin 2%) and EBITDA of ₹86,308 (EBITDA margin 2.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bryos Pharmaceutical is 39% over three years. In the latest year (FY 2024) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
No. Bryos Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Bryos Pharmaceutical is U24239MH2019PTC331568. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bryos Pharmaceutical was incorporated on 11 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Bryos Pharmaceutical by revenue are LN Life Sciences Private Limited, Vaamveda Healthcare Private Limited, Concept Laboratories Pvt Ltd, Damao Pharmaceutical Private Limited, Blazed Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations).
Rajendra Shivmurti Yadav was appointed as Director on 11 Oct 2019. Sanju Rajendra Yadav was appointed as Director on 11 Oct 2019.
The registered office of Bryos Pharmaceutical is at S. No. 119 Room No. 04 Satnam Saheb Chawl Opp. Mahatma Phule School, Dhaniv, Maharashtra, India – 401208.